Pregnancy in chronic kidney disease and kidney transplantation

Kidney International

Volumn 91, Issue 5, 2017, Pages 1047-1056

  Webster, Philip ^a   Lightstone, Liz ^a   McKay, Dianne B ^b   Josephson, Michelle A ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

acute rejection; chronic kidney disease; kidney transplantation; outcomes; pregnancy

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN; FUROSEMIDE; HYDRALAZINE; HYDROXYCHLOROQUINE; ISONIAZID; LABETALOL; LAMIVUDINE; METHYLDOPA; NYSTATIN; TACROLIMUS; TENOFOVIR; VALACICLOVIR; ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; DISEASE COURSE; DRUG SAFETY; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE FERTILITY; GESTATIONAL AGE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO FERTILIZATION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MATERNAL HYPERTENSION; PATIENT COUNSELING; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PROSPECTIVE STUDY; PROTEINURIA; REVIEW; RISK FACTOR; ADVERSE EFFECTS; BLOOD; COMPLICATION; DIRECTIVE COUNSELING; FEMALE; GLOMERULUS FILTRATION RATE; LIVING DONOR; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RENAL INSUFFICIENCY, CHRONIC;

ANTIHYPERTENSIVE AGENTS; ANTIVIRAL AGENTS; CREATININE; DIRECTIVE COUNSELING; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 85012237059     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.10.045     Document Type: Review

References (113)

1. 1 Shahir, A.K., Briggs, N., Katsoulis, J., et al. An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry. Nephrology (Carlton) 18 (2013), 276–284.
2. 2 Alkhunaizi, A., Melamed, N., Hladunewich, M.A., Pregnancy in advanced chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens 24 (2015), 252–259.
3. 3 Jones, D.C., Hayslett, J.P., Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 335 (1996), 226–232.
4. 4 Pregnancy and renal disease. Lancet (London, England) 2 (1975), 801–802.
5. 5 Davison, J.M., Lindheimer, M.D., Pregnancy and chronic kidney disease. Semin Nephrol 31 (2011), 86–99.
6. 6 Jungers, P., Chauveau, D., Choukroun, G., et al. Pregnancy in women with impaired renal function. Clin Nephrol 47 (1997), 281–288.
7. 7 Davison, J.M., Katz, A.I., Lindheimer, M.D., Kidney disease and pregnancy: obstetric outcome and long-term renal prognosis. Clin Perinatol 12 (1985), 497–519.
8. 8 Lindheimer, M.D., Davison, J.M., Pregnancy and the kidney: managing hypertension and renal disease during gestation. Nephrol Self Assess Program 15 (2016), 109–114.
9. 9 National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002), S1–S266.
10. 10 Piccoli, G.B., Cabiddu, G., Attini, R., et al. Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol 26 (2015), 2011–2022.
11. 11 Smith, M.C., Moran, P., Ward, M.K., et al. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG 115 (2008), 109–112.
12. 12 Pamella, S., Ochoa, J.A.V., Comparison of 24-hour urine to estimated renal function using CKD-EPI, MDRD4 and Cockcroft-Gault in specific patient subsets. J Pharm Care Heal Syst, 2015, 2.
13. 13 Côté, A.-M., Lam, E.M., von Dadelszen, P., et al. Monitoring renal function in hypertensive pregnancy. Hypertens Pregnancy 29 (2010), 318–329.
14. 14 Imbasciati, E., Gregorini, G., Cabiddu, G., et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis 49 (2007), 753–762.
15. 15 Zhang, J.-J., Ma, X.-X., Hao, L., et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin J Am Soc Nephrol 10 (2015), 1964–1978.
16. 16 Clowse, M.E.B., Jamison, M., Myers, E., et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199 (2008), 127.e1–127.e6.
17. 17 Bramham, K., Nelson-Piercy, C., Gao, H., et al. Pregnancy in renal transplant recipients: a UK national cohort study. Clin J Am Soc Nephrol 8 (2013), 290–298.
18. 18 Deshpande, N.A., James, N.T., Kucirka, L.M., et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant 11 (2011), 2388–2404.
19. 19 Gill, J.S., Zalunardo, N., Rose, C., et al. The pregnancy rate and live birth rate in kidney transplant recipients. Am J Transplant 9 (2009), 1541–1549.
20. 20 Coscia, L.A., Constantinescu, S., Moritz, M.J., et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl, 2010, 65–85.
21. 21 Levidiotis, V., Chang, S., McDonald, S., Pregnancy and maternal outcomes among kidney transplant recipients. J Am Soc Nephrol 20 (2009), 2433–2440.
22. 22 Sibanda, N., Briggs, J.D., Davison, J.M., et al. Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry. Transplantation 83 (2007), 1301–1307.
23. 23 McKay, D.B., Josephson, M.A., Armenti, V.T., et al. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 5 (2005), 1592–1599.
24. 24 Deshpande, N.A., Coscia, L.A., Gomez-Lobo, V., et al. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev Obstet Gynecol 6 (2013), 116–125.
25. 25 EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant 17 Suppl 4 (2002), 50–55.
26. 26 Fischer, T., Neumayer, H.-H., Fischer, R., et al. Effect of pregnancy on long-term kidney function in renal transplant recipients treated with cyclosporine and with azathioprine. Am J Transplant 5 (2005), 2732–2739.
27. 27 Rose, C., Gill, J., Zalunardo, N., et al. Timing of pregnancy after kidney transplantation and risk of allograft failure. Am J Transplant 16 (2016), 2360–2367.
28. 28 Kasiske, B.L., Anderson-Haag, T., Israni, A.K., et al. A prospective controlled study of living kidney donors: three-year follow-up. Am J Kidney Dis 66 (2015), 114–124.
29. 29 Garg, A.X., McArthur, E., Lentine, K.L., Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med 372 (2015), 1469–1470.
30. 30 Ibrahim, H.N., Akkina, S.K., Leister, E., et al. Pregnancy outcomes after kidney donation. Am J Transplant 9 (2009), 825–834.
31. 31 Reisaeter, A.V., Røislien, J., Henriksen, T., et al. Pregnancy and birth after kidney donation: the Norwegian experience. Am J Transplant 9 (2009), 820–824.
32. 32 Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122 (2013), 1122–1131.
33. 33 Krause, T., Lovibond, K., Caulfield, M., et al. Management of hypertension: summary of NICE guidance. BMJ, 343, 2011, d4891.
34. 34 Lowe, S.A., Brown, M.A., Dekker, G.A., et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust NZ J Obstet Gynaecol 49 (2009), 242–246.
35. 35 Magee, L.A., Helewa, M., Moutquin, J.-M., et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Canada 30 (2008), S1–S48.
36. 36 Bateman, B.T., Bansil, P., Hernandez-Diaz, S., et al. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol 206 (2012), 134.e1–134.e8.
37. 37 Redman, C.W.G., Hypertension in pregnancy: the NICE guidelines. Heart 97 (2011), 1967–1969.
38. 38 von Dadelszen, P., Ornstein, M.P., Bull, S.B., et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet (London, England) 355 (2000), 87–92.
39. 39 Ferrer, R.L., Sibai, B.M., Mulrow, C.D., et al. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 96 (2000), 849–860.
40. 40 Kuklina, E.V., Ayala, C., Callaghan, W.M., Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 113 (2009), 1299–1306.
41. 41 Scantlebury, D.C., Kane, G.C., Wiste, H.J., et al. Left ventricular hypertrophy after hypertensive pregnancy disorders. Heart 101 (2015), 1584–1590.
42. 42 Zanati Bazan, S.G., Borges, V.M., Martin, L.C., et al. Disproportionate pregnancy-induced myocardial hypertrophy in women with essential hypertension. Am J Hypertens 26 (2013), 816–821.
43. 43 Magee, L.A., von Dadelszen, P., Rey, E., et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 372 (2015), 407–417.
44. 44 Hussain, A., Karovitch, A., Carson, M.P., Blood pressure goals and treatment in pregnant patients with chronic kidney disease. Adv Chronic Kidney Dis 22 (2015), 165–169.
45. 45 Mills, K.T., Xu, Y., Zhang, W., et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88 (2015), 950–957.
46. 46 Steel, J.M., Johnstone, F.D., Smith, A.F., et al. Five years’ experience of a “prepregnancy” clinic for insulin-dependent diabetics. BMJ 285 (1982), 353–356.
47. 47 Wilkinson, H., Saving mothers’ Lives. Reviewing maternal deaths to make motherhood safer: 2006-2008. BJOG An Int J Obstet Gynaecol 118 (2011), 1402–1403.
48. 48 Williams, D., Davison, J., Chronic kidney disease in pregnancy. BMJ 336 (2008), 211–215.
49. 49 Hou, S., Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 33 (1999), 235–252.
50. 50 Meuwese, C.L., Carrero, J.J., Chronic kidney disease and hypothalamic-pituitary axis dysfunction: the chicken or the egg?. Arch Med Res 44 (2013), 591–600.
51. 51 Finkelstein, F.O., Shirani, S., Wuerth, D., et al. Therapy insight: sexual dysfunction in patients with chronic kidney disease. Nat Clin Pract Nephrol 3 (2007), 200–207.
52. 52 Davison, J.M., Bailey, D.J., Pregnancy following renal transplantation. J Obstet Gynaecol Res 29 (2003), 227–333.
53. 53 Barua, M., Hladunewich, M., Keunen, J., et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol 3 (2008), 392–396.
54. 54 van Eps, C., Hawley, C., Jeffries, J., et al. Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology (Carlton) 17 (2012), 42–47.
55. 55 National Institute for Health and Care Excellence. Chronic kidney disease in adults: assessment and management. Available at: https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations. Accessed September 26, 2016.
56. 56 International Society of Nephrology. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Available at: http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO_BP_GL.pdf. Accessed September 26, 2016.
57. 57 Gillon, T.E.R., Pels, A., von Dadelszen, P., et al. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS One, 9, 2014, e113715.
58. 58 National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. Available at: https://www.nice.org.uk/Guidance/CG107. Accessed September 26, 2016.
59. 59 Duley, L., Henderson-Smart, D.J., Meher, S., et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev, 2007, CD004659.
60. 60 Stratta, P., Canavese, C., Quaglia, M., Pregnancy in patients with kidney disease. J Nephrol 19 (2006), 135–143.
61. 61 Ferrazzani, S., Caruso, A., De Carolis, S., et al. Proteinuria and outcome of 444 pregnancies complicated by hypertension. Am J Obstet Gynecol 162 (1990), 366–371.
62. 62 Imbasciati, E., Ponticelli, C., Pregnancy and renal disease: predictors for fetal and maternal outcome. Am J Nephrol 11 (1991), 353–362.
63. 63 Smyth, A., Oliveira, G.H.M., Lahr, B.D., et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5 (2010), 2060–2068.
64. 64 Bramham, K., Soh, M.C., Nelson-Piercy, C., Pregnancy and renal outcomes in lupus nephritis: an update and guide to management. Lupus 21 (2012), 1271–1283.
65. 65 Stanhope, T.J., White, W.M., Moder, K.G., et al. Obstetric nephrology: lupus and lupus nephritis in pregnancy. Clin J Am Soc Nephrol 7 (2012), 2089–2099.
66. 66 Buyon, J.P., Kim, M.Y., Guerra, M.M., et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study. Ann Intern Med 163 (2015), 153–163.
67. 67 Thornhill, A.R., deDie-Smulders, C.E., Geraedts, J.P., et al. ESHRE PGD Consortium “Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS).”. Hum Reprod 20 (2005), 35–48.
68. 68 De Rycke, M., Georgiou, I., Sermon, K., et al. PGD for autosomal dominant polycystic kidney disease type 1. Mol Hum Reprod 11 (2005), 65–71.
69. 69 Elsinga, J., de Jong-Potjer, L.C., van der Pal-de Bruin, K.M., et al. The effect of preconception counselling on lifestyle and other behaviour before and during pregnancy. Womens Health Issues 18 (2008), S117–S125.
70. 70 O'Higgins, S., McGuire, B.E., Mustafa, E., et al. Barriers and facilitators to attending pre-pregnancy care services: the ATLANTIC-DIP experience. Diabet Med 31 (2014), 366–374.
71. 71 Wiles, K.S., Bramham, K., Vais, A., et al. Pre-pregnancy counselling for women with chronic kidney disease: a retrospective analysis of nine years’ experience. BMC Nephrol, 16, 2015, 28.
72. 72 Agricola, E., Pandolfi, E., Gonfiantini, M.V., et al. A cohort study of a tailored web intervention for preconception care. BMC Med Inform Decis Mak, 14, 2014, 33.
73. 73 Hamill, L.L., McCance, D.R., Deery, M., et al. Impact of a preconception counselling resource (DVD) on preconception folic acid intake in women with diabetes. Proc Nutr Soc, 73, 2014, E64.
74. 74 McKay, D.B., Josephson, M.A., Pregnancy in recipients of solid organs - effects on mother and child. N Engl J Med 354 (2006), 1281–1293.
75. 75 Kim, H., Jeong, J.C., Yang, J., et al. The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation. Clin Transplant 29 (2015), 142–148.
76. 76 Aktürk, S., Çelebi, Z.K., Erdoğmuş, Ş., et al. Pregnancy after kidney transplantation: outcomes, tacrolimus doses, and trough levels. Transplant Proc 47 (2015), 1442–1444.
77. 77 Hebert, M.F., Zheng, S., Hays, K., et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation 95 (2013), 908–915.
78. 78 Ostensen, M., Disease specific problems related to drug therapy in pregnancy. Lupus 13 (2004), 746–750.
79. 79 Zheng, S., Easterling, T.R., Hays, K., et al. Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. Br J Clin Pharmacol 76 (2013), 988–996.
80. 80 Slabiak-Blaz, N., Adamczak, M., Gut, N., et al. Administration of cyclosporine A in pregnant rats - the effect on blood pressure and on the glomerular number in their offspring. Kidney Blood Press Res 40 (2015), 413–423.
81. 81 Armenti, V.T., Constantinescu, S., Moritz, M.J., et al. Pregnancy after transplantation. Transplant Rev (Orlando) 22 (2008), 223–240.
82. 82 Bramham, K., Chusney, G., Lee, J., et al. Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. Clin J Am Soc Nephrol 8 (2013), 563–567.
83. 83 McKay, D.B., Adams, P.L., Bumgardner, G.L., et al. Reproduction and pregnancy in transplant recipients: current practices. Prog Transplant 16 (2006), 127–132.
84. 84 Coscia, L.A., Constantinescu, S., Davison, J.M., et al. Immunosuppressive drugs and fetal outcome. Best Pract Res Clin Obstet Gynaecol 28 (2014), 1174–1187.
85. 85 Perez-Aytes, A., Ledo, A., Boso, V., et al. In utero exposure to mycophenolate mofetil: a characteristic phenotype?. Am J Med Genet A 146A (2008), 1–7.
86. 86 Sifontis, N.M., Coscia, L.A., Constantinescu, S., et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82 (2006), 1698–1702.
87. 87 Chu, S.-H., Liu, K.-L., Chiang, Y.-J., et al. Sirolimus used during pregnancy in a living related renal transplant recipient: a case report. Transplant Proc 40 (2008), 2446–2448.
88. 88 Guardia, O., Rial, M.D.C., Casadei, D., Pregnancy under sirolimus-based immunosuppression. Transplantation, 81, 2006, 636.
89. 89 Framarino dei Malatesta, M., Corona, L.E., De Luca, L., et al. Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. Transplantation 91 (2011), e69–e71.
90. 90 Jankowska, I., Oldakowska-Jedynak, U., Jabiry-Zieniewicz, Z., et al. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient. Transplant Proc 36 (2004), 3232–3233.
91. 91 Carta, P., Caroti, L., Zanazzi, M., Pregnancy in a kidney transplant patient treated with everolimus. Am J Kidney Dis, 60, 2012, 329.
92. 92 Margoles, H.R., Gomez-Lobo, V., Veis, J.H., et al. Successful maternal and fetal outcome in a kidney transplant patient with everolimus exposure throughout pregnancy: a case report. Transplant Proc 46 (2014), 281–283.
93. 93 Fiocchi, R., D'Elia, E., Vittori, C., et al. First report of a successful pregnancy in an everolimus-treated heart-transplanted patient: neonatal disappearance of immunosuppressive drugs. Am J Transplant 16 (2016), 1319–1322.
94. 94 Carta, P., Zanazzi, M., Minetti, E.E., Unplanned pregnancies in kidney transplanted patients treated with everolimus: three case reports. Transpl Int 28 (2015), 370–372.
95. 95 Veroux, M., Corona, D., Veroux, P., Pregnancy under everolimus-based immunosuppression. Transpl Int 24 (2011), e115–e117.
96. 96 Josephson, M.A., McKay, D.B., Pregnancy and kidney transplantation. Semin Nephrol 31 (2011), 100–110.
97. 97 Kutzler, H.L., Ye, X., Rochon, C., et al. Administration of anti-thymocyte globulin (rabbit) to treat a severe, mixed rejection episode in a pregnant renal transplant recipient. Pharmacotherapy 36 (2016), e18–e22.
98. 98 Østensen, M., Khamashta, M., Lockshin, M., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther, 8, 2006, 209.
99. 99 Anderson, G.G., Rotchell, Y., Kaiser, D.G., Placental transfer of methylprednisolone following maternal intravenous administration. Am J Obstet Gynecol 140 (1981), 699–701.
100. 100 Mariotti, V., Marconi, A., Pardi, G., Undesired effects of steroids during pregnancy. J Matern Fetal Neonatal Med 16 Suppl 2 (2004), 5–7.
101. 101 Hyrich, K.L., Verstappen, S.M.M., Biologic therapies and pregnancy: the story so far. Rheumatology (Oxford) 53 (2014), 1377–1385.
102. 102 Izmirly, P.M., Kim, M.Y., Llanos, C., et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 69 (2010), 1827–1830.
103. 103 Webster, P., Wardle, A., Bramham, K., et al. Tacrolimus is an effective treatment for lupus nephritis in pregnancy. Lupus 23 (2014), 1192–1196.
104. 104 Nadeem, S., Hashmat, S., Defreitas, M.J., et al. Renin angiotensin system blocker fetopathy: a midwest pediatric nephrology consortium report. J Pediatr 167 (2015), 881–885.
105. 105 Cooper, W.O., Hernandez-Diaz, S., Arbogast, P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354 (2006), 2443–2451.
106. 106 Tabacova, S., Little, R., Tsong, Y., et al. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf 12 (2003), 633–646.
107. 107 Velázquez-Armenta, E.Y., Han, J.Y., Choi, J.S., et al. Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature. Hypertens Pregnancy 26 (2007), 51–66.
108. 108 Yakoob, M.Y., Bateman, B.T., Ho, E., et al. The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis. Hypertension 62 (2013), 375–381.
109. 109 Tranquilli, A.L., Giannubilo, S.R., Use and safety of calcium channel blockers in obstetrics. Curr Med Chem 16 (2009), 3330–3340.
110. 110 Genentech. Valcyte (valganciclovir hydrochloride) Patient Support. Available at: http://www.valcyte.com/patient. Accessed September 26, 2016.
111. 111 Yi, W., Liu, M., Cai, H.-D., Safety of lamivudine treatment for chronic hepatitis B in early pregnancy. World J Gastroenterol 18 (2012), 6645–6650.
112. 112 Wang, L., Kourtis, A.P., Ellington, S., et al. Safety of tenofovir during pregnancy for the mother and fetus: a systematic review. Clin Infect Dis 57 (2013), 1773–1781.
113. 113 Bramham, K., Seed, P.T., Lightstone, L., et al. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89 (2016), 874–885.